类风湿关节炎患者抗氨甲酰化蛋白抗体与人纤维蛋白原β链特定表位反应
该研究通过免疫印迹、液相色谱质谱和ELISA(直接结合n=63血清,竞争实验n=40血清)绘制了类风湿关节炎(RA)患者血清中抗氨甲酰化蛋白(anti-CarP)抗体的表位反应性。研究发现anti-CarP抗体主要靶向人纤维蛋白原β链上含高瓜氨酸的特定区域,其中第83位高瓜氨酸可能为免疫优势表位,部分患者体液免疫反应相对局限。
要点
- Anti-CarP抗体优先靶向人纤维蛋白原β链含高瓜氨酸的特定区域。
- 第83位高瓜氨酸可能是部分RA患者血清中的免疫优势表位。
- 部分患者抗体反应相对局限,可能有助于关联疾病表型。
核心结论
- Anti-CarP抗体似乎优先靶向人纤维蛋白原β链上含高瓜氨酸的特定区域。
- 部分患者的体液免疫反应相对局限,可能有助于检测与疾病表型的特定关系。
研究设计与样本
- 通过免疫印迹鉴定对氨甲酰化人纤维蛋白原β链有特定反应性的患者血清样本。
- 采用液相色谱质谱(LC-MS)鉴定人纤维蛋白原β链中高瓜氨酸(氨甲酰化赖氨酸)位点。
- 通过ELISA直接结合(n=63血清)和竞争实验(n=40血清)测定anti-CarP抗体阳性队列对含氨甲酰化赖氨酸特定肽段的反应性。
主要发现
- 从一名RA患者标本中鉴定出对氨甲酰化而非瓜氨酸化纤维蛋白原β链有特定反应性的血清。
- LC-MS鉴定出人纤维蛋白原β链34个赖氨酸中有9个发生氨甲酰化。
- 对胰蛋白酶肽段片段的免疫反应性映射显示多个候选氨甲酰化表位,并经竞争实验确认。
- 含第83位高瓜氨酸的肽段似乎是部分RA患者血清中的免疫优势表位,此外还对含第52、264、351、367和374位高瓜氨酸的肽段有反应性。
关键数值与推荐
- 直接结合实验使用n=63份血清,竞争实验使用n=40份血清。
- 人纤维蛋白原β链34个赖氨酸中鉴定出9个氨甲酰化位点。
- 第83位高瓜氨酸为部分RA患者血清中的免疫优势表位,另发现第52、264、351、367和374位高瓜氨酸的反应性。
临床怎么用
- Anti-CarP抗体表位反应性分析可能有助于理解RA的免疫病理关联。
- 检测针对纤维蛋白原β链特定高瓜氨酸表位的抗体可能辅助关联疾病表型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Anti-carbamylated protein (anti-CarP) antibodies are associated with the risk and severity of rheumatoid arthritis (RA) and are primarily directed against fibrinogen. The lack of understanding of anti-CarP antibody reactivity has limited analysis of the immunopathogenic associations in RA. To address this shortcoming, we mapped anti-CarP antibody epitope reactivity in RA patient sera. METHODS: Immunoblotting identified a patient serum sample with specific reactivity to the carbamylated human fibrinogen β-chain. Liquid chromatography mass spectrometry (LC-MS) identified sites of homocitrullines (carbamylated lysines) present in the human fibrinogen β-chain. The reactivity of an anti-CarP antibody-positive cohort to specific peptides containing carbamylated lysines was determined by enzyme-linked immunosorbent assay, through direct binding (n = 63 sera) and by competition assays (n = 40 sera). RESULTS: Serum with specific reactivity to carbamylated, but not citrullinated, fibrinogen β-chain was identified in a specimen obtained from an RA patient. LC-MS identified carbamylation of 9 of 34 lysines in the human fibrinogen β-chain. Mapping of immunoreactivity to tryptic peptide fragments demonstrated several candidate carbamylated epitopes that were confirmed by competition experiments. Peptides containing a homocitrulline at position 83 appeared to be an immunodominant epitope in some RA patient sera, with additional reactivity to peptides containing homocitrullines at positions 52, 264, 351, 367, and 374. CONCLUSION: Anti-CarP antibodies appear to preferentially target specific regions of the human fibrinogen β-chain that contain homocitrullines. Interestingly, humoral immunoreactivity appears to be relatively restricted in some patients, which may enable detection of specific relationships with disease phenotype.
引用
- Jones JD, Hamilton BJ, Rigby WFC, et al. Brief Report: Anti-Carbamylated Protein Antibodies in Rheumatoid Arthritis Patients Are Reactive With Specific Epitopes of the Human Fibrinogen β-Chain. Arthritis Rheumatol. 2017. PMID: 28296337. doi:10.1002/art.40098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。